Ignite Creation Date:
2024-05-06 @ 9:12 AM
Last Modification Date:
2024-10-26 @ 12:11 PM
Study NCT ID:
NCT02927340
Status:
UNKNOWN
Last Update Posted:
2021-03-09
First Post:
2016-09-26
Brief Title:
A Study of Lorlatinib in Advanced ALK and ROS1 Rearranged Lung Cancer With CNS Metastasis in the Absence of Measurable Extracranial Lesions
Sponsor:
Massachusetts General Hospital
Organization:
Massachusetts General Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Non-Small Cell Lung Cancer NSCLC |
Keywords:
| Name | View |
|---|---|
| Lung Cancer | View |